Sign in
4

Changes in Ownership

Jasper Therapeutics, Inc. Filed Acc 0001213900-24-078214

Chief Operating Officer sold 900 shares at $21.23 ($19,104)

  • Chief Operating Officer acquired 900 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mahal Jeetinder Singh · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-12 Exercise or conversion : show line 1 in the form 10b5-1 +900 $7.10 $6,390 25,909 D
2024-09-12 Sale : show line 2 in the form 10b5-1 −900 $21.23 $19,104 25,009 D
Open-market sales · 900 sh · avg $21.23 · $19,104

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-12 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) +900 14,672 D
Loading xslF345X05/ownership.xml…